

The Genex Power Ltd (ASX: GNX) share price is lifting once more after a consortium of suitors, including the investment fund of Atlassian (NASDAQ: TEAM) co-founder Scott Farquhar, slapped the stock with another takeover bid.
And this one looks like it could stick. The consortium, made up of Farquhar’s Skip Capital and Stonepeak Partners, has offered 25 cents per share to snap up the company. That’s 2 cents higher than its previously rejected offer.
The Genex share price is surging on the news. It’s up 6.82% to 23.5 cents at the time of writing, after repeatedly topping 8% throughout the day.
Let’s take a closer look at the latest from the renewable generation and storage company.
Genex share price soars on upped takeover bid
It’s been a long journey to get here, but Genex has finally granted Skip Capital’s infrastructure fund and Stonepeak Partners due diligence.
The consortium first put forward a 23 cent per share bid, valuing the renewable energy company at $300 million, in late July.
And while the market responded with joy, sending the Genex share price 44% higher, the company wasn’t impressed. Its board turned down the offer earlier this month, saying it undervalued the company.
Though, it allowed the consortium access to some due diligence information in the hopes doing so would result in a higher bid.
And lo and behold, a higher bid has materialised. The new offer represents an 85% premium on the undisturbed Genex share price and a 92% premium on its three-month volume weighted average.
It also values the company at around $346 million.
The company’s board hopes the consortium follows its proposal with a binding bid after it undergoes due diligence.
If such a bid is priced at 25 cents per share or higher, Genex will recommend it to shareholders. That’s as long as an independent expert agrees it’s in investors’ best interests and no better offer comes along.
If all goes to plan, the consortium will snap up Genex via a scheme of arrangement in the not-so-distant future.
The post Genex share price leaps 8% on revised takeover bid from Atlassian founder appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now
See The 5 Stocks
*Returns as of August 4 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Genex share price climbs 6% amid new takeover rumours
- ‘Massive untapped demand’: The $3 trillion opportunity ASX 200 energy shares could be missing
- No deal: Genex share price lifts as $300m takeover bid rejected
- Genex share price rockets 50% on confirmed takeover bid
- Genex share price in focus amid Atlassian co-founderâs $300m takeover bid
Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Atlassian. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/iG9wzYm
Leave a Reply